Bill Gates and Jeff Bezos to Fund 'First Commercial Neural Interface'

Gates Frontier and Bezos Expeditions are investing $75 million in Synchron.The deal was part of the Series "C" financing for the

business development.The total amount of funding raised by the company since its founding has already amounted to $145 million. The funds received will be used to support and promote the development of the first product of the Synchron platform - the brain-computer neural interface Synchron Switch, as well as to begin the main clinical trial.

Neurointerface Synchron Switch. Video: Synchronization

Brain Computer Interface Synchron Switchdesigned to detect and wirelessly transmit motor intentions from the brain. This will bring back the ability for severely paralyzed patients to control their personal devices using point-and-click functionality, hands-free. The device is implanted into a blood vessel on the surface of the motor cortex through the jugular vein in a minimally invasive endovascular procedure, the company says.

Neurointerface Synchron Switch. Images: Synchron

Synchron received permission fromThe U.S. Food and Drug Administration (FDA) to conduct clinical trials involving humans as early as July 2021, overtaking the main competitor, Neuralink, Elon Musk. The aim of the first study was to implant a device called Stentrode into the brain so that paralyzed patients could control the cursor with the "power of thought".

We have the opportunity to provide the first ina class-leading commercial brain-computer interface. The problem of paralysis is much more serious than people think. 100 million people around the world are affected by the work of the upper limbs.

Tom Oxley, MD, CEO and Founder of Synchron

Read more:

Hydrogen energy, material against cold weather and bioadditives against COVID-19: what scientists are creating in the North

Scientists have found out who benefited from the death of dinosaurs

Look at the photo of the Earth from space: it was made by the first private module